GH Research (GHRS)
(Delayed Data from NSDQ)
$8.01 USD
-0.49 (-5.76%)
Updated Sep 10, 2024 04:00 PM ET
After-Market: $8.01 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value F Growth A Momentum F VGM
Income Statements
Fiscal Year end for GH Research PLC falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 41 | 31 | 15 | 0 | 0 |
Income After Depreciation & Amortization | -41 | -31 | -15 | 0 | 0 |
Non-Operating Income | 6 | 7 | 6 | 0 | 0 |
Interest Expense | 1 | -1 | 0 | 0 | 0 |
Pretax Income | -36 | -22 | -9 | 0 | 0 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -36 | -22 | -9 | 0 | 0 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -36 | -22 | -9 | 0 | 0 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -41 | -31 | -15 | 0 | 0 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -41 | -31 | -15 | 0 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 52.33 | 51.98 | 43.61 | NA | NA |
Diluted EPS Before Non-Recurring Items | -0.68 | -0.43 | -0.21 | NA | NA |
Diluted Net EPS (GAAP) | -0.68 | -0.43 | -0.21 | -0.01 | NA |
Fiscal Year end for GH Research PLC falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 13.22 | 11.53 | 11.16 | 9.72 | 9.93 |
Income After SG&A, R&D, and Dept/Amort Expenses | -13.22 | -11.53 | -11.16 | -9.72 | -9.93 |
Non-Operating Income | 3.02 | 4.04 | 0.08 | 4.25 | 2.38 |
Interest Expense | 0.18 | 0.18 | 0.19 | 0.18 | 0.18 |
Pretax Income | -10.38 | -7.67 | -11.27 | -5.65 | -7.73 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -10.38 | -7.67 | -11.27 | -5.65 | -7.73 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -10.38 | -7.67 | -11.27 | -5.65 | -7.73 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 51.90 | 51.11 | 53.68 | 51.36 | 51.53 |
Diluted EPS Before Non-Recurring Items | -0.20 | -0.15 | -0.21 | -0.11 | -0.15 |
Diluted Net EPS (GAAP) | -0.20 | -0.15 | -0.21 | -0.11 | -0.15 |